A review of the efficacy and tolerability of antipsychotic long ‐acting injections

The formulation of long‐acting injections (LAIs) as a method of delivering antipsychotics can be used to improve adherence, particularly in those unintentionally non‐adherent. Here, the authors review the efficacy and tolerability of first‐generation antipsychotic (FGA) and second‐generation antipsychotic (SGA) LAIs, analyse drug cost, give guidance on initiation regimens for SGA LAIs and discuss the future for these drugs.

Source: Progress in Neurology and Psychiatry - September 13, 2016 Category: Neurology Authors: Allison Whyte, Caroline Parker Tags: Review Source Type: research